ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Risk Assessment of PSA Recurrent Prostate Cancer"
Episode Synopsis
As part of the 2024 Prostate Cancer Patient Conference, Dr. Mack Roach discusses the phenomenon of “biochemical recurrence” and approaches to risk assessment, following treatments for localized prostate cancer.
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 39761]
More episodes of the podcast UC San Francisco (Video)
The Trouble with Nutritional Supplements
17/12/2025
The Benefits of HIIT Training
26/11/2025
New Treatments for Advanced Prostate Cancer
06/10/2025
Overview: PSA Recurrent Prostate Cancer
15/09/2025
In God we trust